Skip to main content
. 2022 Aug 3;43(10):5783–5794. doi: 10.1007/s10072-022-06287-2

Table 4.

Demographic and clinical factors associated with immunization in the whole sample

Model 1 OR (95% CI) p
Higher EDSS 0.6 (0.4–0.9) 0.006
Model 2
AntiCD20 treatment 0.02 (0.003–0.098)  < 0.001

Model 1 included as a covariate treatment with DMTs (yes/no); model 2 treatment with antiCD20 vs other DMTs/no treatment

Legend: OR, odds ratio; CI, confidence interval; DMTs, disease-modifying therapies.